Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Media source
Main topic
Secondary mention della SISSA o di una (ex) persona SISSA
Is it triggered by our press release/brief?
No
Copy and paste of our text?
No
Interview organised by us (with/without press release or note, comment, event, etc…)
No
Copy and paste of an agency news (wherever it comes from)?
No